Back

Effects of serotonin agonists LSD and 25CN-NBOH on conditioned place preference and on synaptic plasticity of VTA dopamine neurons in mice

Elsila, L. V.; Nagaeva, E.; Luukkonen, J.-P.; Korpi, E. R.

2024-12-17 pharmacology and toxicology
10.1101/2024.12.12.628157 bioRxiv
Show abstract

The current research on psychedelic compounds such as lysergic amide diethylamide (LSD) is leaning heavily on the notion that psychedelics are not addictive. While much of the literature supports this argument, some of the common use patterns and the descriptions of the subjective effects of these compounds in humans, together with rather lacking and mixed data from non-human animal studies leave room for questions of potentially rewarding or reinforcing stimulus effects. Initiated by a surprising finding in a control study, we investigated these potential rewarding effects of LSD and a selective 5-HT2A agonist 25CN-NBOH using both unbiased and biased designs of conditioned place preference as well as ex vivo patch-clamp electrophysiology measurements of glutamatergic synaptic plasticity on midbrain ventral tegmental area (VTA) dopamine neurons in C57Bl6/J mice. Our results showed no reliable formation of place preference with either compound, agreeing with previous claims of psychedelics having at most weak reinforcing effects. However, we did observe single doses of the drugs, especially LSD, inducing synaptic plasticity in the medially located VTA dopamine neurons, implicating a role for the midbrain dopamine system in the effects of psychedelic drugs. Graphical abstractTreatment with mixed serotonin receptor agonist, psychedelics lysergic acid diethylamide (LSD) or selective serotonin 2A receptor agonist 25CN-NBOH did not cause reliable induction of conditioned place preference in C57Bl/6J mice. However, we did observe single doses of the drugs, especially LSD, inducing synaptic plasticity in the medially located VTA dopamine neurons. These findings challenge some of the previous rodent data but are in general in line with the claims of psychedelics having at most weak reinforcing effects. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=143 SRC="FIGDIR/small/628157v1_ufig1.gif" ALT="Figure 1"> View larger version (38K): org.highwire.dtl.DTLVardef@57a87org.highwire.dtl.DTLVardef@1af3827org.highwire.dtl.DTLVardef@8fb256org.highwire.dtl.DTLVardef@5504b_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Frontiers in Pharmacology
100 papers in training set
Top 0.1%
14.3%
2
Psychopharmacology
59 papers in training set
Top 0.1%
10.4%
3
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.1%
10.1%
4
Drug and Alcohol Dependence
37 papers in training set
Top 0.1%
8.4%
5
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.1%
6.8%
6
Neuropharmacology
60 papers in training set
Top 0.1%
6.4%
50% of probability mass above
7
Journal of Psychopharmacology
14 papers in training set
Top 0.1%
4.8%
8
British Journal of Pharmacology
34 papers in training set
Top 0.1%
4.3%
9
Neuropsychopharmacology
134 papers in training set
Top 0.9%
3.6%
10
International Journal of Neuropsychopharmacology
11 papers in training set
Top 0.1%
2.1%
11
The Journal of Pharmacology and Experimental Therapeutics
15 papers in training set
Top 0.1%
2.1%
12
Scientific Reports
3102 papers in training set
Top 51%
2.1%
13
PLOS ONE
4510 papers in training set
Top 50%
1.9%
14
Brain Sciences
52 papers in training set
Top 0.7%
1.7%
15
Pharmaceutics
21 papers in training set
Top 0.3%
1.2%
16
Life Sciences
25 papers in training set
Top 0.9%
1.2%
17
Translational Psychiatry
219 papers in training set
Top 4%
0.9%
18
Pharmaceuticals
33 papers in training set
Top 1%
0.9%
19
Addiction Neuroscience
17 papers in training set
Top 0.5%
0.8%
20
ACS Chemical Neuroscience
60 papers in training set
Top 2%
0.8%
21
Addiction Biology
47 papers in training set
Top 0.7%
0.8%
22
International Journal of Molecular Sciences
453 papers in training set
Top 14%
0.8%
23
Journal of Psychiatric Research
28 papers in training set
Top 0.7%
0.8%
24
Frontiers in Psychiatry
83 papers in training set
Top 3%
0.7%
25
Neurotherapeutics
11 papers in training set
Top 0.5%
0.7%
26
Frontiers in Public Health
140 papers in training set
Top 9%
0.7%
27
Nicotine and Tobacco Research
13 papers in training set
Top 0.3%
0.6%
28
eLife
5422 papers in training set
Top 61%
0.6%